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ABSTRACT 
Cloning, Expression and Characterization of Novel Fungal 
Endoglucanases 
Hua Nan Ren 
Global energy consumption is projected to double between 1980 and 2020. 
Furthermore, about 65% of present energy consumption is derived by burning 
nonrenewable fossil fuels that increase atmospheric levels of CO2. the major 
greenhouse gas implicated in global warming. It is therefore important that carbon 
neutral alternative energy sources be developed. For transportation fuels bioethanol 
derived from renewable energy sources is considered among the most attractive 
alternatives. Presently, most bioethanol is produced from corn kernels and sugar cane 
sucrose, with the United State and Brazil being the world's major producers. 
Cellulose is another possible feedstock that can be used to produce bioethanol. 
Compared with the currently used feedstocks, cellulose is very abundant in nature and 
its use for biofuels production would not compete with the food or animal feed 
industries. In order to use cellulose for bioethanol production, the cellulose must be 
converted into the fermentable sugar glucose. Currently, the high cost of converting 
the cellulose into glucose is a major impediment to using cellulose as a feedstock for 
the production of bioethanol. The goal of my research was to address this issue by 
discovering new fungal enzymes that could improve the cellulose hydrolyzing 
efficiency of existing commercial cellulase systems. In this study I identified, cloned, 
functionally expressed and characterized six endoglucanases, AfumEgl2010, 
iv 
AnidEgl2020, FgraEgl2010, FgraEgll020, FgraEgl2020 and NcraEgl2010. Three of 
these endoglucanases, AfumEgl2010, AnidEgl2020, FgraEgl2010, were characterized 
in detail in this study. Only AfumEgl2010 harbours a carbohydrate-binding module 
(CBM). All three of the endoglucanases that were subject to detailed characterization 
show highest activity at pH 5.0. The temperature optima of these three 
endoglucanases were determined to be 40°C, 60°C and 70°C. All of them were stable 
during 30 minutes pre-incubation at 60°C. The kinetic parameters of these three 
endoglucanases and four other endoglucanases, the Trichoderma reesei (T. reesei) 
Eg2/Cel5A and ApulSEQ15654, StheSEQ13822, GtraSEQ630 (previously identified 
by undergraduate student Christopher St-Francois) were determined at 37°C and the 
pH optima of each endoglucanase. The Km values ranged from 2.0 to 29 mg/ml. The 
Vmax values ranged from 5.7 to 41 umole/mg/min. The degree of synergism when 
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1. Introduction 
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1.1 Traditional and alternative resources used for energy 
Energy demand has increased dramatically in the last one hundred years (Sun and 
Cheng, 2002). To meet the demand of energy consumption, worldwide energy production 
has increased by 118 percent from 1970 to 2006 (DOE/EIA-0384(2008)). The traditional 
resources used for energy are mainly fossil fuels including oil, coal and natural gas 
(http://www.energy.gov/energysources/fossilfuels.htm). In 2006, the energy produced by 
burning fossil fuels accounted for 86 percent of total energy production in the world 
(DOE/EIA-0384(2008)). Fossil fuels are finite and take a very long time to generate 
(DOE/GO-102001-1102). We therefore need to find alternative energy resources. In 2006, 
renewable energy and nuclear electric power accounted for 8 percent and 6 percent 
respectively of total energy production in the whole world (DOE/EIA-03 84(2008)). 
Renewable energy is generated from renewable sources such as hydroelectric power, 
biofuels, wood, wind, geothermal, waste, and solar (DOE/EIA-0384(2008)). Compared 
with fossil fuels, renewable energy sources can be renewed in a short period of time and 
their use reduces greenhouse gas emissions (DOE/GO-102001-1102). For example, the 
use of bioethanol, produced from renewable cellulosic biomass as a transportation fuel 
can reduce greenhouse gas emission relative to using gasoline produced from fossil fuels 
(Wang et al., 2007). 
2 
1.2 Bioethanol 
Bioethanol has the potential to replace gasoline in the transportation sector. In Brazil, 
the United States, some European countries and Canada, bioethanol is already in use. 
Essentially all the bioethanol that is presently produced is made by fermentable sugars 
generated from different types of raw materials (Galbe and Zacchi, 2007). 
1.2.1 Bioethanol produced from starch- and sugar- based crops 
Currently, bioethanol is generated mainly from starch- and sugar- based crops such as 
corn and sugar cane (Galbe and Zacchi, 2007). The advantage of using these feedstocks 
to produce bioethanol is that the cost of production stays competitively low (Galbe and 
Zacchi, 2007). The disadvantage of using these feedstocks is that starch- and sugar- based 
crops are agricultural crops, therefore using these feedstocks to produce bioethanol 
competes with food and feed production (Sun and Cheng, 2002). In the United States, 
bioethanol is produced mainly from corn and in Brazil the bioethanol is produced mainly 
from sugar cane (DOE/EIA-0383(2007)). In 2008, the United States produced 9.2 billion 
gallons of bioethanol (http://www.eia.doe.gov/conference/2009/session5/session5.pdf ). 
The cost of production of bioethanol from corn ranged from 60 cents to 80 cents per liter 
of gasoline equivalent (http://www.iea.org/techno/essentials2.pdf). Brazil produced more 
than 6.4 billion gallons of bioethanol in 2008 according to Uniao da Agroindustria 
Canavieira (Unica) and Renewable Fuels Association 
(http://www.ethanolrfa.Org/industry/statistics/#E). The cost of production of bioethanol 
using sugar cane ranged from 25 cents to 35 cents per liter of gasoline equivalent 
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1.2.2 Bioethanol produced from cellulosic biomass 
Another way to produce bioethanol is to use cellulosic biomass from plants, 
agricultural residues, forestry wastes, and paper waste (DOE/EIA-0383(2007)). The 
advantages of using cellulosic biomass are that it is very abundant in nature, it does not 
compete with food and feed production, and it has potential to reduce greenhouse gas 
emissions (Galbe and Zacchi, 2007; Sun and Cheng, 2002). The review paper by Sun and 
Cheng (2002) reported that in the past 20 years there has been significant research 
focusing on the conversion of cellulosic feedstocks to bioethanol. There are two main 
steps that are required to convert cellulosic feedstocks to bioethanol: 1) hydrolysis of 
hemicellulose and cellulose of feedstocks to fermentable sugars 2) conversion of the 
sugar into ethanol through a fermentation step (Sun and Cheng, 2002). Currently, the 
main challenge of using cellulosic biomass to produce bioethanol as a transportation fuel 
is the relatively high cost of production of bioethanol (Galbe and Zacchi, 2007). For 
instance, currently the cost of production of bioethanol using cellulosic biomass is over 1 
dollar per liter of gasoline equivalent (http://www.iea.org/techno/essentials2.pdf). One 
reason for the high cost of bioethanol production is the relatively low efficiency of 
feedstock conversion to fermentable sugars (Sun and Cheng, 2002). 
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1.3 Cellulose and hemicellulose 
Cellulose is the major component in plant cell walls and it is very abundant in nature 
(Bayer et al., 1998). Cellulose is a linear polymer of many D-glucose units that are linked 
by P-(l, 4) - glucosidic bonds (Crawford, 1981; Updegraff, 1969). The individual 
cellulose chains can hydrogen bond with each other to form a cellulose microfibril 
(Albersheim, 1975). Cellulose microfibrils can assume both a crystalline structure and an 
amorphous structure (Purves et al., 1998). Figure 1 shows the structure of a cellulose 
microfibril. 
Hemicellulose is another major component in plant cell walls and accounts for 20 to 
35 percent of lignocellulosic biomass (Saha, 2003). Hemicellulose is a branched 
heteropolymer with a P-(l, 4) linked backbone (Rose, 2003). In plant cell walls, the 
hemicellulose can be linked to cellulose via hydrogen bonds (Rose, 2003). The linkage 
between hemicellulose and cellulose makes less cellulose available for enzymatic 
degradation thereby reducing both the efficiency of the enzymatic hydrolysis of cellulose 
and the yield of fermentable sugars (Sun and Cheng, 2002). 
Crystalline array Cellulose 
of molecules in microfibri l 
a micelle 
Figure 1: The structure of a cellulose microfibril (Purves et al., 1998). Reprinted from 
"Life: The Science of Biology, Fifth Edition" Copyright (2009), with permission from 
SINAUER ASSOCIATES, Inc. 
1.4 Cellulases 
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1.4.1 Background of cellulases and cellulase systems 
Enzymes that hydrolyze the p-1, 4-glucosidic bonds in the cellulose chain are called 
cellulases (Bayer et al., 1998). Cellulases are glycoside hydrolases (EC 3.2.1.-), which 
are enzymes responsible for the breakdown of glycosidic bonds between carbohydrates 
(http://www.cazv.org/fam/acc_GH.html). Cellulases are produced by a wide variety of 
species, such as fungi, bacteria, plants and animals such as termites and crayfish (Lynd et 
al., 2002). The major role of cellulases in bacterial and fungal species is to break down 
cellulose into an energy form that they can readily use (Lynd et al., 2002). The function 
of cellulases in plants involves construction and decomposition of their cell walls 
(Urbanowicz et al., 2007). Many cellulases have a catalytic domain linked via a shorter 
linker to a carbohydrate-binding module (CBM) (Lynd et al., 2002). The major function 
of the CBM of cellulases is to bind to insoluble cellulose, which brings the catalytic 
domain closer to the insoluble cellulose and therefore increases the efficiency of cellulose 
hydrolysis (Lynd et al., 2002). Another possible function of the CBM is to partially 
separate cellulose strands from the surface of cellulose microfibrils, thereby making the 
cellulose strands more accessible for hydrolysis (Din et al., 1994). 
The collection of cellulase enzymes that are produced by a strain of bacteria or fungus 
are called cellulase enzyme systems (Lynd et al., 2002). In general, there are two 
different types of cellulase enzyme system. One type is produced by anaerobic bacteria, 
while the other type is produced by aerobic bacteria and fungi (Lynd et al., 2002). In 
anaerobic bacteria, the enzymes that are produced form stable high-molecular weight 
7 
complexes (Lynd et al., 2002). These complex cellulase systems, also known as 
cellulosomes, are responsible for the degradation of cellulose by these organisms (Lynd 
et al., 2002). Aerobic bacterial and fungal organisms produce multiple cellulase enzymes 
that do not associate to form stable high-molecular weight complexes (Lynd et al., 2002). 
1.4.2 Classification of cellulases 
There are three major types of cellulases: endoglucanases (EC 3.2.1.4), exoglucanases 
which are either cellodextrinases (EC 3.2.1.74) or cellobiohydrolases (EC 3.2.1.91), and 
P-glucosidases (EC 3.2.1.21) (Lynd et al., 2002). Endoglucanases hydrolyze cellulose at 
internal amorphous sites and reduce the length of the cellulose chain, thus creating more 
reducing and non-reducing chain ends (Lynd et al., 2002). Exoglucanases hydrolyze the 
cellulose chain from either the reducing or non-reducing end and the major final products 
are cellobiose or glucose (Lynd et al., 2002). Another function of exoglucanases is the 
release of single cellulose molecules from the cellulose microfibril structure (Teeri, 1997). 
P-glucosidases break down cellobiose and cellodextrins into glucose (Lynd et al., 2002). 
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Figure 2: The role of three major cellulases in the hydrolysis of cellulose (Percival 
Zhang et al., 2006). The endos represents endoglucanases, the exosR and exosNR 
represents exoglucanases that act at the reducing and non reducing ends of cellulose 
polymer, and the p-Gase represents p-glucosidases (Percival Zhang et al., 2006). 
Reprinted from "Outlook for cellulase improvement: Screening and selection strategies" 
Copyright (2009), with permission from Elsevier. 
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1.4.3 Classification of endoglucanases (EC 3.2.1.4) of Trichoderma reesei 
There are five endoglucanases present in the T. reesei cellulase system (Lynd et al., 
2002). They are Cel7B (Egl), Cel5A (Egll), Cell2A (Eglll), Cel61A (EglV), and Cel45A 
(EgV). The most abundant endoglucanases present in the T. reesei cellulase system are 
Cel7B and Cel5A (Lynd et al., 2002). Except for Cell2A, all the major T. reesei 
endoglucanases harbour a CBM (Karlsson et al., 2002). The 3D structures of the catalytic 
domains of Cel7B and Cell2A of T. reesei are already solved and both have similar 3D 
structures consisting of an open glove structure that can bind to cellulose strands 
(Kleywegt et al., 1997; Sandgren et al., 2001). The 3D structures of the other 3 T. reesei 
endoglucanases have not been elucidated. 
1.4.4 Commercial cellulases in industrial applications 
According to the review paper of Lynd et al. (2002), the cellulases that are the most 
widely used in the cellulosic bioethanol industry are produced from T. reesei and 
Aspergillus species. One commercial cellulase system includes minimally two 
exoglucanases (CBHI and CBHII), five endoglucanases (Egl to EgV), and two p-
glucosidases (Bgll and Bglll) all produced from T. reesei (Lynd et al., 2002). In addition, 
p-glucosidase produced from Aspergillus species has been used to supplement the T. 
reesei cellulase in some commercial cellulase preparations (Lynd et al., 2002). The p-
glucosidase from Aspergillus species is added because it is more tolerant to glucose 
inhibition than are the two P-glucosidases produced by T. reesei (Lynd et al., 2002). 
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1.5 Synergism 
Cellulase synergism occurs when cellulases working together show higher activity 
levels than the level of activity obtained by adding the activities of the individual 
cellulases working under the same conditions (Lynd et al., 2002). Four types of 
synergism have been described (Lynd et al., 2002): 1) synergy between endoglucanases 
and exoglucanases (Henrissat et al., 1985; Nidetzky et al., 1993) 2) synergy between 
exoglucanases (Henrissat et al., 1985; Tomme et al., 1988) 3) synergy between 
exoglucanases (endoglucanases) and P-glucosidases (Lamed et al., 1991; Woodward, 
1991) 4) synergy between the CBM and catalytic domain of individual cellulases (Din et 
al., 1994). It has been suggested that the synergy between endoglucanases and 
exoglucanases is due to two types of cooperative activity. Firstly, endoglucanases 
working on the amorphous sites of cellulose chains create more chain ends that can be 
hydrolyzed by exoglucanases (Henrissat et al., 1985). Secondly, exoglucanases release 
cellulose molecules from the cellulose microfibril making the cellulose more accessible 
to endoglucanases (Teeri, 1997). Synergy between exoglucanases occurs because CBHI 
acts on the reducing ends of the cellulose chain and CBHII acts on the non-reducing ends 
of cellulose chains (Teeri, 1997). Both endoglucanase and exoglucanase activity can be 
inhibited by the accumulation of cellobiose (Gruno et al., 2004). Since P-glucosidase can 
break down cellobiose to glucose, there is synergism when P-glucosidase is added to 
reactions with endoglucanases or exoglucanases (Lamed et al., 1991). Lastly the 
intramolecular synergy between the CBM and the catalytic domain of cellulases occurs 
because CBM binding to the cellulose substrate brings the catalytic domain to the 
substrate surface and the CBM loosens the crystalline structure by partially separating the 
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cellulose strands from the surface of cellulose microfibrils making the substrate easier to 
hydrolyze (Din et al., 1994). 
The degree of synergism is the ratio between the measured activity of a cellulase 
mixture and the sum of individual activity of each cellulase in the mixture (Zhang and 
Lynd, 2004). There are several factors that can affect the degree of synergism such as the 
degree of polymerization of the substrate, the amount of enzyme loading, and the reaction 
time (Zhang and Lynd, 2004). 
1.6 Expression vector and expression system 
In our laboratory, integrating plasmids are used to express proteins in Aspergillus 
niger (A niger) (Storms et al., 2005). The integrating plasmids were constructed using 
several cassettes: 1) a pUC18 derivative for selection and maintenance in E. coli; 2) a 
pyrG cassette for selection of A. niger transformants; 3) an expression cassette that 
includes the glucoamylase promoter region (GlaPr) and glucoamylase transcription 
termination region (GlaTt) for directing gene expression; 4) lacA reporter gene cassette 
flanked by unique Nhel and Fsel restriction cut sites; and 5) the attRl and attR2 
recombinant cassette (Invitrogen) in the Gateway destination vector (Storms et al., 2005). 
The A. niger glucoamylase promoter is a strong promoter that can direct high levels of 
expression (Carrez et al., 1990; Fowler et al., 1990; Hata et al., 1992; Jeenes et al., 1993; 
Santerre Henriksen et al., 1999; Verdoes et al., 1993; Withers et al., 1998). In this study, 
two integrating plasmids, which were previously constructed in our laboratory using the 
12 
above cassettes (Storms et al., 2005), were used. These plasmids are shown in Figure 3 
and Figure 4. 
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Figure 3: The integrating vector ANIp5. ANIp5 contains the Ap/pUC18 cassette 
which includes the ampicillin resistance gene and a bacterial origin of replication. The 
selectable marker cassette contains the Aspergillus nidulans pyrG gene that is used as a 
selectable marker for A. niger transformations. The glucoamylase promoter region (GlaPr) 
and glucoamylase termination region (GlaTt) regulate the transcription and transcription 
termination of the cloned gene. The reporter gene cassette includes the coding region of 
the A. niger lacA gene. lacA is replaced by the target genes during directional cloning 
using the Nhel and Fsel restriction enzyme sites. 
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Figure 4: The integrating vector ANIp7G. ANIp7G is an integrating vector. It is used 
for "Gateway recombination" cloning. ANIp7G was constructed by ligating the attRl and 
attR2 Gateway recombination cassette (Invitrogen) into the Nhel restriction site of ANIp7. 
CmR and ccdB indicate the chloramphenicol resistance gene and ccdB gene. 
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1.7 Objective 
Currently the cost of production of bioethanol from cellulose is much higher than the 
cost of producing gasoline from fossil fuels. One major problem is the low efficiency of 
the cellulases used to hydrolyze cellulose to fermentable sugars. Thus my objective was 
to look for new highly efficient cellulases that could replace the existing cellulases in the 
commercial cellulase systems or create an altogether new cellulase system. To achieve 
this objective I: cloned target genes that encoded putative hemicellulases, cellulases and 
accessory proteins from several fungal species; heterologously expressed them in A. niger, 
screened the expressed enzyme for high endoglucanase activity; and subjected several 
functionally expressed endoglucanases to biochemical characterization. 
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2. Material and Methods 
2.1 Bioinformatics analysis 
I cloned two sets of fungal genes into our expression vectors. The cDNA-derived set 
included 113 cDNA genes that were part of a collection of about full length 2000 cDNAs 
identified previously (Semova et al., 2006) and cloned into a Gateway Donor vector, 
pDONR 201. This set of genes coded for cellulases, hemicellulases and cellulose 
accessory proteins. Since these genes were already partially characterized, I used the 
following criteria to select a subset for further analysis: 1) A. niger transformed with the 
gene expressed an active enzyme at significant levels as assessed by enzyme assays of the 
culture filtrate; 2) and/or A. niger transformed with the gene expressed the target protein 
at a significant level as assessed by SDS-PAGE analysis of the culture filtrate. The 
genomic DNA-derived set of genes were identified using the protein sequences of 11 
previously characterized enzymes, 9 cellulases, one cellobiose dehydrogenase, and one 
swollenin (Table 2) to search the genomes of 13 fungal species (Table 3) using the Basic 
Local Alignment Search Tool (BLAST) (Altschul et al., 1990) "tbalstn". In this study, I 
have functionally expressed and biochemically characterized three endoglucanases that 
were encoded by three genes from the genomic DNA-derived set. These three 
endoglucanases AfumEgl2010, AnidEgl2020, and FgraEgl2010 were identified by a 
tblastn search of the Aspergillus fumigatus, Aspergillus nidulans, and Fusarium 
graminearum genomes using the protein sequence of the T. reesei Eg2/Cel5A (Genebank 
accession #: Ml9373) as query. I also performed enzyme kinetic and synergy assays on 
three endoglucanases (ApulSEQ15654, GtraSEQ630 and StheSEQ13822) that were 
17 
encoded by three genes from cDNA-derived set. Potential signal peptides were predicted 
by using the SignalP 3.0 server tool (http://www.cbs.dtu.dk/services/SignalP-3.0/) 
(Bendtsen et al., 2004). Conserved domains and glycoside hydrolase families were 
predicted by using the A Conserved Domain Database and Search Service, v2.17 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) (Marchler-Bauer et al., 2009) at 
National Center for Biotechnology Information (NCBI). Protein sequences were aligned 
using ClustalW2 (matrix setup "blosum") from EMBL-EBI 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html) (Larkin et al., 2007). The molecular 
mass of the proteins was estimated using the EXPASY Compute pI/Mw tool 
(http://www.expasv.ch/tools/pi_tool.html) (Bjellqvist et al., 1993). Swiss-model software 
was used to predict the 3-D structures of proteins (http://swissmodel.expasy.org//SWISS-
MODEL.html) (Arnold et al., 2006; Kiefer et al., 2009 ; Peitsch, 1995). 
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Table 1: The fungal species used as the source of mRNA for cloning the cDNA-derived set 
















American Type Culture Collection Strain # 62921 
Canadian Collection of Fungal Cultures Strain # DAOM194228 
Okayama 7 
American Type Culture Collection Strain # 11539 
University of Alberta Microfungus collection and Herbarium (UAMH) # 6337 
University of Alberta Devonian Botanic Garden Microfungus Collection & Herbarium Strain # UAMH 1568. 
American Type Culture Collection Strain # 48564 
American Type Culture Collection Strain # 90774 
Forintek Culture Collection Strain # FCC 55A 
USDA Forests Products Laboratory Strain # RP78 
American Type Culture Collection Strain # 42464 
American Type Culture Collection Strain # 200065 
Wild type strain A733 (Fungal Genomic Stock Group, Kansas City, Kansas 
American Type Culture Collection Strain #36112 
Paprican strain 52P (ATCC 20869) 
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Table 2: The query genes that were used to identify the 207 target genes in the 
genomic DNA-derived set 
















Bgll/Cel3 Aspergillus niger 
Bgl5/ HGT-BG Aspergillus oryzae 
CDH/CDH3 Phanerochaete chrysosporium 













 Cellobiose dehydrogenase and Swollenin act as accessory proteins during cellulose 
degradation. 
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Table 3: The fungal species used as the source of genomic DNA templates that were 
used to clone the genomic DNA-derived set 














Fungal Genetics Stock Center # Al 100 
Fungal Genetics Stock Center # A4 
Fungal Genetics Stock Center # Al 143 
ATCC 6205 
Fungal Genetics Stock Center # 9003 
Fungal Genetics Stock Center # 9075 
Fungal Genetics Stock Center #9596 
Fungal Genetics Stock Center # 2489 
Fungal Genetics Stock Center # 9002 
P. sojae strain P6497 obtained from Dr. Gijzen 
from University of Western Ontario 
Fungal Genetics Stock Center # 9543 
Fungal Genetics Stock Center # 9021 
Fungal Genetics Stock Center # 10004 
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2.2 Strains and plasmid 
cDNA clones from the 15 fungal species presented in Table 1 were used as the source 
of the full length ORF templates that were cloned to generate the cDNA-derived set. The 
13 fungal species presented in Table 3 were used as the source of genomic DNA to 
amplify putative genes that encoded cellulases and accessory proteins to generate the 
genomic DNA-derived set. Heterologous proteins were expressed in A. niger strain N593 
AglaA::hisG (Storms et al., 2005) and strain CBS 513.88 (personal communication, 
Anja Riemens). E. coli strain DH5a was used as the host strain for recombinant plasmid 
construction and routine plasmid propagation. E. coli strain ToplO was used as host strain 
for the propagation of recombinant entry clones and expression clones when using the 
Gateway cloning system (Invitrogen). E. coli strain DB3.1 (F- gyrA462 endAl glnV44 
A(srl-recA) mcrB mrr hsdS20(rs', m^) aral4 galK2 lacYl proA2 rpsL20(Sm) xyl5 Aleu 
mtll) (Bernard and Couturier, 1992; Miki et al., 1992), purchased from Invitrogen, was 
used as host strain for propagating the Donor vector, pDONR 201, (Invitrogen) and the 
Gateway Destination vector ANIp7G. 
The integrating plasmid ANIp5 (Storms et al., 2005) was used to construct the 
expression clones by directional cloning. The integrating plasmid ANIp7G, constructed 
by ligating the attRl and attR2 Gateway recombination cassette (Invitrogen) into the 
Nhel restriction site of ANIp7 plasmid, was used to construct the Gateway expression 
clones (Storms et al., 2005). 
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2.3 Media and culture conditions 
For directional cloning, E. coli cultures of the expression clones were incubated in LB 
medium containing 100 ug/ml ampicillin for 14-16 hours at 37°C in a shaking incubator 
at 200 rpm. For cloning using the Gateway in vitro recombination system, E. coli cultures 
of entry clones were incubated in LB medium containing 50 pg/ml kanamycin for 14-16 
hours at 37°C incubator shaking at 200 rpm. E. coli cultures of expression clones were 
incubated in LB medium containing 100 pg/ml ampicillin for 14-16 hours in a 37°C 
shaking at 200 rpm. The LB medium was made of 1% (w/v) bio-tryptone, 0.5% (w/v) 
yeast extract, and 1.0% (w/v) NaCl. Complete medium (CM) was prepared as described 
previously (Kafer, 1977). Minimal medium J (MMJ), is the same as minimal medium 
(MM) (Kafer, 1977) except the amount of nitrate salts, MgSO/t, and trace elements were 
4 times higher than MM and 15 % (w/v) maltose was used as the carbon source. MMJ 
was used to grow liquid cultures of A. niger harbouring the target endoglucanases. 
Saline-Tween solution was 0.5% (w/v) NaCl and 0.002% (v/v) Tween-80. 
2.4 Cloning 
2.4.1 Directional cloning 
2.4.1.1 Gene amplification 
Full-length cDNA clones isolated from the species listed in Table 1 (Semova et al., 
2006) were used as the source of template DNAs for amplifying the cDNA-derived target 
genes. Genomic DNA isolated from 13 different fungal species (Table 3) was used as the 
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template for amplifying the genomic DNA-derived target genes. The genomic DNA was 
isolated using the Qiagen DNeasy Plant Mini Kit (Qiagen) following the manufacturer's 
protocol with one minor modification. Harvested mycelia were ground to a fine powder 
using liquid nitrogen. 
The 3' ends of the forward and reverse primer pairs that were used to amplify each 
target gene harboured 18 to 25 nucleotides complementary to the template strand and the 
nontemplate strand respectively. The region of the oligo that hybridized to the template 
strand of each gene began at the A residue of the start codon and extended into the coding 
region. The region of the oligo that hybridized to the non coding strand began at the third 
base of the stop codon and extended towards the start codon. The 5' end of the forward 
primers started with the filler nucleotides AGAAT to increase the digestion efficiency of 
restriction enzyme Nhel, followed by GCTAGC, the sequence for Nhel recognition, and 
then ATA to insert Kozak consensus sequence nucleotides for A. niger immediately 
before the start codon. The 5' end of each reverse primer began with filler nucleotides 
AGACTA to increase the digestion efficiency of restriction enzyme Fsel, followed by 
the Fsel recognition sequence, GGCCGGCC immediately adjacent the 18-25 nucleotides 
that are complementary to the target gene. For target genes that harboured a Nhel 
restriction site, Spel or Xbal were used to replace the Nhel restriction site in the forward 
primers. 
PCR amplification was carried out in 50 pi reactions using Pfu buffer with MgS04. 
Each gene amplification contained 0.375 units of Pfu polymerase, 0.75 units of Taq 
polymerase and 100 ng of fungal genomic DNA. The final concentration of dNTPs and 
primers were 0.2 mM and 0.5 uM. The PCR program used to perform the gene 
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amplifications was the Touchdown PCR program (Don et al., 1991). The initial cycles in 
the touchdown PCR program start at an annealing temperature higher than the Tm of the 
primers and then decrease 0.5°C per cycle until the annealing temperature reaches or is 
even below the Tm of the primers (Don et al., 1991). To check for the amplification of 
fragments of the correct size, 5 u.1 of each PCR product was fractionated on a 1% agarose 
gel. PCR products of the correct size were gel-purified using the GE Healthcare "GFXtm 
PCR DNA and Gel Band Purification Kit" following the method provided by the 
manufacturer. The purified PCR products were double digested with either restriction 
enzyme Nhel, Spel or Xbal, and Fsel and then ligated into the prepared backbone of 
expression vector ANIp5. 
2.4.1.2 Backbone preparation 
To prepare the backbone for directional cloning, ANIp5 was first digested with Nhel 
and Fsel. Next, the digested product was fractionated on a 1% agarose gel and the vector 
backbone band of 5562 bp was cut from the agarose gel and extracted using a GE 
Healthcare "GFXtm PCR DNA and Gel Band Purification Kit". 
2.4.1.3 Plasmid construction and E. coli transformation 
ANIp5 backbone and inserts were mixed and ligated for 2 hours at room temperature. 
Five ul of each ligation product was mixed with 40 pi of E. coli DH5a competent cells, 
followed by incubation on ice for 30 minutes. The mixture was then subjected to a heat 
shock at 37°C for 5 minutes. The mixture was added to 100 pi of LB medium and 
incubated for 45 minutes at 37°C and 250 rpm. Each transformation mix was spread on 
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an LB agar plate containing 100 pg/ml ampicillin and the plate was incubated overnight 
at 37°C. 
Three putative expression colonies obtained with each insert were inoculated in LB + 
Amp medium and incubated for 14-16 hours at 37°C with shaking. The plasmid DNAs 
were extracted using Qiagen Plasmid Miniprep Kits (Qiagen) following the 
manufacturer's instructions. To determine whether clones with the correct insert were 
isolated, the expression clones were digested with Sad and the digestion products were 
fractionated on 1 % agarose gels. Plasmids harbouring inserts of the correct size were 
subjected to DNA sequencing to verify that they contained a faithful copy of the desired 
ORF. 
2.4.2 Gateway cloning 
2.4.2.1 Gene amplification 
Forward and reverse primers that were used to generate attB-PCR products for 
Gateway cloning were designed following the guidelines in the Gateway Technology 
manual (Invitrogen). The 5' end of forward primers start with GGGG, then the 25 
nucleotide attBl site ACAAGTTTGTACAAAAAAGCAGGCT, followed by 18 to 25 
nucleotides of gene specific sequence. The 5' end of each reverse primer also starts with 
GGGG, then the 25 nucleotides attB2 site ACCACTTTGTACAAGAAAGCTGGGT, 
followed by 18 to 25 nucleotides of gene specific sequence. The attB-PCR products were 
amplified and purified as described in section 2.4.1.1. 
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2.4.2.2 BP recombination reaction and E. coli transformation 
The BP recombination reaction was performed with Gateway BP Clonase™ Enzyme 
Mix (Invitrogen) and the provided protocol with the following modification. In each BP 
recombination reaction, 2 pi of pDONR 201 vector (30 ng/p.1) was mixed with 1 pi 5x BP 
Clonase™ Reaction buffer, 0.5 pi of the Gateway BP Clonase™ enzyme mix, and 0.5 pi 
of TE buffer (pH 8.0). One pi of the attB-PCR produced from the gene amplification step 
was added into the BP master mix. The BP recombination reaction was incubated at 25°C 
overnight. The BP recombination reaction was terminated by adding 2 pg of Proteinase K. 
After the Proteinase K was added, the mixture was vortexed briefly and incubated at 
37°C for 10 minutes. To transform the desired BP recombination products into competent 
cells, firstly, 2.5 pi of each BP recombination reaction mixture was mixed with 40 pi E. 
coli Top 10 chemically prepared competent cells. Secondly, the transformation procedure 
was performed as described in section 2.4.1.3. Finally, the transformed cells were spread 
on an LB agar plate containing 50 pg/ml kanamycin. The plate was incubated overnight 
in a 37°C incubator. 
A single colony of each entry clone was inoculated in LB + Kan medium at 37°C and 
incubated with shaking for 14-16 hours. Plasmid DNA extractions of putative entry 
clones were done as described in section 2.4.1.3. To confirm the entry clone had the 
correct insert, the entry clone was digested with BsrGI, the digestion mixture was run on 
1% agrose gel and the resulting banding pattern for each clone was examined to 
determine whether the desired fragment had been recombined into the backbone of the 
Gateway Donor vector. 
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2.4.2.3 LR recombination reaction and E. coli transformation 
The LR recombination reaction was performed with Gateway LR Clonase™ Enzyme 
Mix (Invitrogen) and the manufacturer's protocol with the following modifications. In 
each LR recombination reaction, 2 pi of ANIp7G vector (30 ng/pl) was mixed with 1 pi 
5x LR Clonase™ Reaction buffer, 0.5 pi Gateway LR Clonase™ Enzyme Mix, and 0.5 
pi TE buffer (pH 8.0). One pi of the desired entry clone generated in the BP 
recombination reaction step was added into the LR recombination reaction. The LR 
recombination reaction was incubated at 25°C overnight. The same procedures were used 
to terminate and transform the BP and LR recombination reactions except that the 
transformed E. coli Top 10 chemical treated competent cells were spread on an LB agar 
plate containing 100 pg/ml ampicillin. A single colony of each expression clone was 
inoculated in LB + Amp medium and incubated at 37°C with shaking for 14-16 hours. 
Plasmid DNA extraction and clone confirmation were performed as described in section 
2.4.2.2. 
2.4.3 DNA Sequencing 
The inserts in each expression clone were sequenced at the Genome Quebec 
Innovation Centre (McGill University). The same universal forward and reverse primers 
were used for sequencing the ANIp7G and ANIp5 clones (forward primer: 5'-
TGCTTCTTCCTTCAGCTTCC-3', reverse primer: 5'-
ATGACTTGGCTTCCATTTCAC-3'). 
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2.5 A. niger protoplast formation and transformation 
A. niger protoplasts used for transformation were prepared as described previously 
(Debets and Bos, 1986) with some modifications. Recently harvested conidia (less than 
two weeks old) were used to inoculate a flask of liquid CM medium at a concentration of 
2x10 conidia/ml. The mycelia after 16-18 hours growth were harvested by filtration 
through Miracloth. The mycelial mass was washed with 100 ml 0.6 M MgS04.then dried 
and weighed. For every 2 grams of mycelium 10 ml OM solution (1.6 mM NaH2P04, 8.4 
mM Na2HP04, and 1.2 M MgS04-7H20) and 1 ml of (3-glucannase solution (250mg/ml) 
were added to the mycelium to digest the cell wall. After 2.5 to 3 hours incubation in a 
30°C shaking incubator at 100 rpm, the protoplast suspension was transferred into a 50 
ml centrifuge tube, and an equal volume of ice-cold TB-layer (0.6 M sorbitol and 0.1 M 
Tris-HCl pH 7.5) was added carefully and slowly onto the protoplast suspension to avoid 
mixing of the two layers. After centrifugation, the protoplasts were harvested from the 
interface between the TB layer and OM layer. The harvested protoplast solution was 
centrifuged and washed three times with ice cold S/C solution (1 M sorbitol and 50 mM 
CaCl2). Following the last wash the protoplasts were resuspended in ice cold S/C solution 
at a final concentration of 1x10 protoplasts/ml. 
Transformation was done as described previously (Wernars et al., 1987) with several 
modifications. Two hundred pi of protoplast suspension was mixed with 20 pi 0.4 M 
ATA (aurintricarboxylic acid), 1 to 5 pg of plasmid DNA, and a 100 pi solution of 20% 
(w/v) polyethyleneglycol (PEG) 4000, 16.7 mM CaCl2, 3.3 mM Tris-HCl pH 7.5, and 
incubated at room temperature for 10 minutes. After the 10 minute incubation, 1.5 ml 
PEG 4000 solution (60% (w/v) PEG 4000 , 50 mM CaCl2, 10 mM Tris-HCl pH 7.5) was 
29 
added, mixed, and incubated at room temperature for another 20 minutes. Five ml of 1.2 
M sorbitol was added and the solution was mixed carefully. The mixture was centrifuged 
at room temperature for 10 minutes at 4000 rpm, and the pellet was then resuspended in 1 
ml 1.2 M sorbitol. The transformed protoplasts were finally plated on MM agar plates 
with 4.47% (w/v) KCl using MM with 4.47% (w/v) KCl and 1.5% agar overlayer for 
selection (Storms et al., 2005). Plates were incubated for 4 to 6 days in a 30°C incubator 
until individual transformants appeared. 
2.6 Microtiter plate culture growth and initial screening 
Recombinant versions of expression vectors ANIp5 and ANIp7G with the cloned 
cellulase and accessory protein genes were introduced into A. niger strain N593 A 
glaAr.hisG using the protoplast generation and transformation method described above. 
Microtiter plate cultures were inoculated as described previously (Master et al., 2008). 
A toothpick soaked in saline-tween was used to harvest conidia from the surface of a 
single colony on transformation plates (MM + 4.47% (w/v) KCl). Conidia on the tip of 
the toothpick were used to inoculate individual 200 pi MMJ medium cultures in the 
individual wells of a microtiter plate. The microtiter plate cultures were grown for 4 to 6 
days inside a styrofoam or plastic box lined on the bottom with paper towels soaked in 
water and incubated at 30°C without shaking. The medium from each culture was 
harvested and transferred into 96 well PCR plates using a multi-channel pipettor. 
Initial screening for endoglucanase activity was performed using agar plates 
containing carboxylmefhylcellulose (CMC) sodium salt and activity staining with Congo 
red essentially as described previously (Wood et al., 1988). To prepare the CMC agar 
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plate, 0.5% (w/v) CMC (degree of substitution: 0.65-0.90) sodium salt (Sigma) and 1.5% 
(w/v) agar (Bioshop) were dissolved in 100 mM citrate buffer pH 5.0 and poured into 
NUNC OmniTray single-well plates (VWR). Three pi of culture medium suitably diluted 
with 10 mM citrate buffer pH 5.0 was then spotted in duplicate on two CMC agar plates. 
The plates were incubated upside down at 37°C overnight. Both CMC agar plates were 
stained with 0.05% (w/v) Congo red solution for 20 to 30 minutes and then destained 
with 0.5% (w/v) NaCl for 20 to 30 minutes. The destaining step was repeated until clear 
spots were visible. 
2.7 Petri dish culture growth and purification of enzymes 
Petri dish cultures were inoculated as described previously (Master et al., 2008) with 
the following modification. 15 ml of MMJ medium was inoculated using conidia 
resuspended in saline-Tween to a final concentration of lxlO6 conidia/ml. The growth 
conditions were the same as those used for the microtiter plate cultures described in 
section 2.6. 
Culture supernatant was centrifuged for 15 minutes at 3000 rpm and 4°C to pellet the 
mycelia. The supernatant was then filtered through Ultrafree-0.5 centrifugal filter devices 
(Millipore) to remove small molecules including sugars, following the manufacturer's 
instructions. A maximum of 500 pi of culture supernatant was loaded into the Ultrafree-
0.5 centrifugal filter device. The supernatant was centrifuged for 30 minutes at 10,000 
rpm and 4°C to bring the volume of supernatant from 500 pi down to 20 pi. The 20 pi of 
concentrated culture supernatant was washed five times by adding 500 pi of citrate buffer 
(10 mM, pH 5.0) to the filter device and centrifuging for 30 minutes at 10,000 rpm and 
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4°C. During each washing step, if the remaining volume of solution after centrifugation 
was greater than 20 pi, an extra centrifugation step was done to bring the final volume of 
solution down to 20 pi. After five washes, the solution that remained on the filter was 
transferred into a microfuge tube. The Ultrafree-0.5 centrifugal filter device was then 
washed with 480 pi of citrate buffer (10 mM, pH 5.0) and the retained liquid was 
combined with the previously transferred solution. Purified enzymes were stored at -80°C. 
2.8 Three cDNA-derived target genes 
The ApulSEQ15654, StheSEQ13822, and GtraSEQ630 genes were amplified from 
cDNA and cloned into the pGBFIN-GTW vector (Tsang et al., 2008). The recombinant 
versions of expression vector pGBFIN-GTW were introduced into A. niger strain 
CBS513.88 and the culture filtrate purified to remove sugar using an Ultrafree-0.5 
centrifugal filter device, as described above. 
2.9 SDS-PAGE and enzyme concentration determination 
SDS-PAGE analysis was performed using a 12%, 10 well precast polyacrylamide gel 
(DGel Science). Proteins were visualized by staining with Coomassie blue R250 (Biorad). 
In order to estimate the protein concentration, different amounts (0.25 pg, 0.5 pg, 
0.75 pg, and 1 pg) of BSA (Albumin, bovine serum fraction V, -99% purity, protease 
free, essentially r-globulin free, Sigma) were loaded adjacent to the suitably diluted 
endoglucanases on the same SDS-PAGE gel. After the proteins were stained with 
Coomassie blue R250, an image of the gel was taken using the Gene Genius Bio Imaging 
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System (Syngene). To estimate the concentration of each endoglucanase, Gene Tools 
(Version 3.08.03) was used. 
2.10 Enzyme assays 
2.10.1 Enzyme activity assay 
Endoglucanase activity was determined by measuring the production of reducing 
sugar ends. The assay was performed in 133 mM citrate buffer (pH 5.0) at 37°C using 
filter paper disks as substrate (Xiao et al., 2004). The amount of reducing sugar ends 
produced were quantitated using the bicinchoninic acid (BCA) assay adapted for 96-well 
microtiter plates as previously described (Doner and Irwin, 1992 ; Grishutin et al., 2004; 
Zorov et al., 1997). Ten pi of enzyme reaction mixture was added to the wells of a 96-
well PCR plate containing 90 pi of H20 and 100 pi of BCA mixture (Doner and Irwin, 
1992 ; Grishutin et al., 2004; Zorov et al., 1997). The BCA mixture contains equal 
volumes of reagent A [5.43% (w/v) of Na2C03, 2.42% (w/v) of NaHC03, and 0.1942% 
(w/v) 2'2 bicinchoninic disodium BCA] and reagent B [0.125% (w/v) CuS045H20, 
0.126% (w/v) L-serine]. The assay mixtures were incubated for 40 minutes at 80°C in a 
heating block. Once the incubation was finished, the plate was transferred into an ice box 
and then centrifuged for 3 minutes at 3000 rpm. Eighty pi of the BCA reaction mixture 
was removed and the absorbance was determined at 562 nm using PowerWave™ HT 
microplate scanning spectrophotometer (Bio-Tek). In order to convert the absorbance 
into the amount of reducing sugar ends, a standard curve was generated using D-glucose 
(5 pM to 25 pM, final concentration of D-glucose in BCA assay). One unit of enzyme 
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activity is defined as 1 pmole of reducing sugar ends released per minute at 37°C. All 
assays were done in triplicate. 
2.10.2 Enzyme pH profiles 
To determine the pH profile of each endoglucanase, the microplate filter paper assay 
was performed as previously described (Xiao et al., 2004) with the following 
modifications. Glycine-HCl buffer (pH 2.0 to 3.0), citrate buffer (pH 3.0 to 6.0), and 
sodium phosphate buffer (pH 6.0 to 8.0) were used to generate the pH range. Twenty pi 
of suitably diluted enzyme (diluted in 10 mM citrate buffer, pH 5.0) was mixed with 40 
pi of 200 mM buffer at the desired pH and a filter paper disk in the wells of a 96-well 
PCR plate. The reactions were carried out for 60 minutes at the optimal temperature of 
each endoglucanase (in the case of AnidEgl2020 it was at 60°C, AfumEgl2010 at 70 °C, 
and FgraEgl2010 at 40 °C). To terminate the reaction the 96-well PCR plate was 
transferred on ice, and 10 pi of each reaction mixture was removed and a BCA assay was 
performed as described in section 2.10.1. 
2.10.3 Enzyme temperature profiles 
The microplate filter paper assay (Xiao et al., 2004) was also used to determine the 
temperature profile of each endoglucanase with the following modifications. Twenty pi 
of suitably diluted enzyme was mixed with 40 pi of 200 mM citrate buffer (pH 5.0) and a 
filter paper disk in the wells of a 96-well PCR plate. The enzyme assay was incubated for 
60 minutes at the following temperatures: 25°C, 30 °C, 37 °C, 50 °C, 60 °C, 70 °C, and 
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80°C. The reactions were terminated by placing the PCR plate on ice and the BCA assay 
was performed as described in section 2.10.1. 
2.10.4 Enzyme thermostability profiles 
To determine each enzyme's thermostability, a microplate filter paper assay was 
performed as previously described (Xiao et al., 2004) with the following modifications. 
Twenty pi of suitably diluted enzyme was incubated with 40 pi of 200 mM citrate buffer 
(pH 5.0) for 30 minutes without the addition of a filter paper disk at the following 
temperatures: 25°C, 30 °C, 37 °C, 50 °C, 60 °C, 70 °C, and 80°C. The enzyme buffer 
mixture was cooled down on ice and transferred into another 96-well PCR plate 
containing the filter paper disk. The plate was incubated for 60 minutes at 37°C. Finally, 
the amount of reducing sugar ends produced were determined using the BCA assay 
performed as described in section 2.10.1. 
2.11 Enzyme kinetics 
Enzyme kinetic parameters were estimated at 37°C and the optimal pH of each 
endoglucanase. Parallel assays were also performed with a commercial endoglucanase, 
the T. reesei Eg2/Cel5A (Iogen Corp.). Phosphoric acid swollen cellulose (PASC) was 
used as the substrate. PASC was prepared as described previously (Wood, 1988) with the 
following modifications. 5 grams of minicrystalline cellulose PH-105 Avicel (Sigma) 
was resuspended in 150 ml of 85% (w/v) phosphoric acid. The suspension was slowly 
stirred for 3 hours at 4°C. After adding two liters of ice cold distilled H20, the suspension 
was stirred vigorously for 15 minutes. The suspension was centrifuged for 10 minutes at 
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14,000 g and 4°C. The precipitated cellulose was washed several times with ice cold 
distilled H20 until the pH was between 5.0 and 7.0. The pellet formed during the final 
centrifugation was resuspended in 10 mM citrate buffer pH 5.0. Finally, a blender was 
used to generate a homogeneous mixture. The final concentration of PASC used in the 
enzyme assays ranged from 0.05% (w/v) to 1% (w/v). Each enzyme assay consists of 40 
pi of each endoglucanase at a known concentration (Table 4), 60 pi of 3.3 X buffer at 
each endoglucanase's optimal pH (Table 5) and 100 pi of different concentrations of 
PASC in a 96-well flat bottom microplate. Enzyme kinetic parameters were determined 
using enzyme and substrate concentrations that resulted in a linear increase of reducing 
sugar ends with time. Enzyme hydrolysis was carried for 60 minutes at 37°C with 
shaking at 250 rpm. The reaction mixtures were mixed using a multi-channel pipettor 
until the solution was homogeneous and then 10 pi aliquots were transferred at intervals 
of 5 minutes over a 60 minute time course into a new 96-well PCR plate. The amount of 
reducing sugar ends produced was determined using the BCA assay as described in 
section 2.10.1. The values of pmoles of reducing sugar ends produced per minute per mg 
of enzyme with variable concentration of PASC were used to determine the kinetic 
parameters of each endoglucanase using the GraFit v6.0 software program (Erithacus 
Software Limited), by fitting to the Michaelis-Menten equation. 
Table 4: The final concentration of target enzymes used in the kinetic assays 







Eg2/Cel5A (Iogen)3 7.2 
3
 T. reesei Eg2/Cel5A obtained from Iogen Corporation. 
Table 5: The final concentration and pH of the buffers used for determining enzyme 
kinetic parameters and synergism 
Name of enzyme Buffer 
Eg2/Cel5A (Iogen)3 60 mM Citrate buffer pH 5.0 
AnidEgl2020 60 mM Citrate buffer pH 5.0 
AfumEgl2010 60 mM Citrate buffer pH 5.0 
FgraEgl2010 60 mM Citrate buffer pH 5.0 
ApulSEQl 5654 44 mM Mcllvaine buffer pH 4.5 
StheSEQl 3822 49 mM Mcllvaine buffer pH 6.0 
GtraSEQ630 44 mM Mcllvaine buffer pH 4.5 
a
 T. reesei Eg2/Cel5A obtained from Iogen Corporation. 
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2.12 Synergy assay 
The substrates used for the synergy assays were 1% (w/v) Avicel (Sigma) and 1% 
(w/v) PASC. PASC was prepared as described in section 2.11. 1% (w/v) Avicel was 
prepared by suspending 1 gram of Avicel in 100 ml of 10 mM citrate buffer (pH 5.0). In 
order to assess synergism of enzyme mixtures, five different combinations (Table 6) of 
each endoglucanase and the T. reesei exoglucanase (Cbhl/Cel7A) (Iogen Corp.) were 
mixed in a final volume of 20 pi. The 20 pi enzyme mixtures were added to 30 pi of 3.3 
X optimal pH buffer (Table 5) and 50 pi of 1% (w/v) PASC or 1% (w/v) Avicel in the 
well of a 96-well flat bottom microplate. The activity of each enzyme was determined as 
follows. Four different concentrations of each endoglucanase and the T. reesei 
exoglucanase (Cbhl/Cel7A) (Iogen Corp.) (Table 7) were assayed by combining 20 pi of 
appropriately diluted enzyme, 30 pi of 3.3 X optimal pH buffer (Table 5) and 50 pi of 1% 
(w/v) PASC or 1% (w/v) Avicel (personal communication, Rasha Cheikh-Ibrahim). The 
enzyme assays were carried out for 120 minutes in a shaking incubator at 250 rpm and 
37°C. The BCA assay (as described in section 2.10.1) was performed to follow the 
production of reducing sugar ends. 
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Table 6: The final concentrations of the T. reesei exoglucanase (Cbhl/Cel7A) and 
endoglucanases that were present in the 20 pi of enzyme mixtures that were added 








































 T. reesei Cbhl/Cel7A obtained from Iogen Corporation. 
Table 7: The final concentration of exoglucanase and endoglucanase enzymes that 
were present in the 20 pi samples used to perform assays with various 
concentrations of the individual enzyme 



























 T. reesei Cbhl/Cel7A obtained from Iogen Corporation. 
3. Results 
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3.1 Cloning and plasmid construction 
The 113 target genes in the cDNA-derived set that were selected from over 2,000 
cDNA-derived fungal Gateway entry clones (Semova et al., 2006) were transferred into 
the integrating plasmid ANIp7G in order to test whether they could be expressed in A. 
niger strain N593 AglaA::hisG. The Gateway LR recombination reaction (described in 
section 2.4.2.3) was used to move the target gene from the entry clone into the expression 
vector ANIp7G. To verify the correct target gene was cloned into the expression vector, 
the restriction enzyme BsrGI was used to digest each putative expression clone. The 
digestion results showed that 70 out of thel 13 target genes were successfully cloned into 
the integrating plasmid. Table 8 lists the 113 target genes in the cDNA-derived set. 
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I also cloned a set of 207 genomic DNA-derived genes. The genomic DNA-derived 
set was PCR amplified from genomic DNA prepared as described in section 2.4.1.1. 
Directional cloning was used to clone 142 of the 207 genomic DNA-derived genes, 
whereas Gateway recombination was used to clone 65 of the 207 genomic DNA-derived 
genes. The amplified target genes were cloned into either integrating plasmid ANIp5 or 
ANIp7G using directional cloning and Gateway recombination, respectively (as 
described in sections 2.4.1 and 2.4.2). For expression clones generated using the 
directional cloning method, Sad restriction enzyme digests were used to confirm the 
target gene had been cloned. Restriction enzyme BsrGI was used to verify that the 
Gateway cloning was successful. Based on the restriction enzyme digestion results, 149 
out of 207 target genes were successfully cloned into the integrating plasmids. Table 9 
shows the list of 149 cloned genes, and Figure 5 shows the results of 1% agarose gel 
elecrophoretic analysis of the restriction digests. 
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3773, 1747,690, 133 
3773, 1613, 1370, 180 
3773, 2309, 857 
3773, 3959 
3773, 1974, 1685,749,229,75 
3773, 3292 





 Gene that was successfully cloned into ANIp5 based on restriction enzyme analysis. 
Location of the lanes in Figure 5A harbouring the positive clones. 
c





Figure 5A: SacI restriction enzyme screening results to identify the positive genomic 
DNA-derived clones presented in Table 9A. The lane marked X is a clone that did not 
harbour the expected. 
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3773, 2674, 857 
3773, 2989 














 Columns designated as indicated for Table 9A. 
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Figure 5B: SacI restriction enzyme screening results to identify the positive genomic 
DNA-derived clones presented in Table 9B. The lane marked X is a clone that did not 
harbour the expected. 
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Row#l, lanel 
Row# 1, lane2 
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Row#l, lane4 
Row#l, lane5 









































 Genes that was successfully cloned into ANIp7G based on restriction enzyme analysis. 
b
 Location of the lanes in Figure 5C harbouring the positive clones. 
0
 BsrGI fragments obtained and expected for positive clones. 
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Figure 5C: BsrGI restriction enzyme screening results to identify the positive 
genomic DNA-derived clones presented in Table 9C. 























































Columns designated as indicated for Table 9A. 
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Figure 5D: SacI restriction enzyme screening results to identify the positive genomic 
DNA-derived clones presented in Table 9D. The lane marked X is a clone that did not 
harbour the expected 
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 Columns designated as indicated for Table 9A. 
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Figure 5E: SacI restriction enzyme screening results to identify the positive genomic 
DNA-derived clones presented in Table 9E. The lane marked X is a clone that did not 
harbour the expected. 
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AnidEgl4050 Row#2, lanel 0 5619,800,25 
CcinEgl4030 Row#2, lanel 1 5619,1288 
3
 Gene that was successfully cloned into ANIp5 based on restriction enzyme analysis. 
b
 Location of the lane in Figure 5F harbouring the positive clones. 
c
 SacI fragments obtained and expected for positive clones. 
d
 Gene that was successfully cloned into ANIp7G based on restriction enzyme analysis. 
e
 BsrGI fragments obtained and expected for positive clones. 
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Figure 5F: SacI or BsrGI restriction enzyme screening results to identify the positive 
genomic DNA-derived clones presented in Table 9F. The lane marked X is a clone that 
did not harbour the expected 
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Figure 5G: SacI or BsrGI restriction enzyme screening results to identify the 
positive genomic DNA-derived clones presented in Table 9G. 
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Genes were successfully cloned by Yan Li. 
Gene that was successfully cloned into ANIp5 based on restriction enzyme analysis. 
c
 Location of the lane in Figure 5H harbouring the positive clones. 
SacI fragments obtained and expected for positive clones. 
e
 Gene that was successfully cloned into ANIp7G based on restriction enzyme analysis. 
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Figure 5H: SacI or BsrGI restriction enzyme screening results to identify the 
positive genomic DNA-derived clones presented in Table 9H. 
61 
3.2 Sequencing 
I successfully cloned a total of 149 genomic DNA-derived genes and 70 cDNA-
derived genes. Since the cDNA-derived genes were previously sequenced as entry clones, 
DNA sequencing was only performed on the genomic DNA-derived genes. The 
sequencing results were compared with the target gene DNA sequence downloaded from 
two fungal genome databases (JGI and BROAD INSTITUTE). Summarizing the 
sequencing results, 41 of the completely sequenced target genes were 100% identical 
with the fungal genome database sequence. Two completely sequenced target genes had a 
1 base pair difference that resulted in a silent mutation. Two of the completely sequenced 
target genes had 1 or 2 base pair difference within an intron. 39 partially sequenced target 
genes (with about 500 bp reads from each end) were found to be 100% identical with the 
gene in the respective fungal genome sequence. The remaining 65 sequenced target genes 
were found to differ from the genome sequences by at least one base pair that changed 
the encoded protein. 
Three target genes were biochemically characterized. The DNA sequence of two of 
these genes, AnidEgl2020 and FgraEgl2010 were 100% identical with the publicly 
available gene sequences, whereas AfumEgl2010 was identical to its gene sequences in 
the sequenced genomes over the 788 nucleotides that were sequenced; however about 
600 nucleotides of the cloned gene still need to be sequenced. 
3.3 A niger transformations and microtiter plate-scale culture growth 
The A. niger host strain N593 A glaA::hisG was transformed (as described in section 
2.5) with 74 out of the 149 plasmid constructions (genomic DNA-derived set) that were 
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verified by restriction enzyme digestion. Figure 6 shows an example of A. niger 
transformation results. Sixty out of the 74 clones harbouring the expected gene inserts 
were screened using microplate culture filtrates (Figure 7) (as described in section 2.6) to 
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Figure 6: A. niger transformation. A. A. niger strain N593 AglaA::hisG transformants 
obtained with ANIp7G-NcraEgl2010. Each colony represents an individual transformant. 
B. Results obtained when the transformation procedure was performed without the 
inclusion of plasmid DNA. Since A. niger strain N593 zl glaA::hisG is pyrG', the 
untransformed protoplasts can not survive on MM plate without uracil and uridine. 
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•VTO 
Figure 7: Microtiter plate cultures of individual transformants for ANIp7G-
NcraEgI2010. The VTO (vector transformants only) is A niger strain N593 A 
glaA hisG transformed with integrating plasmid ANIp7G without a target gene 
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3.4 Screening for functionally-expressed endoglucanases 
The initial screening to identify functionally-expressed target endoglucanases was 
performed as described in section 2.6. The screening of 51 endoglucanase genes 
(genomic DNA-derived set) identified six that were functionally expressed. They were 
AfumEgl2010, AnidEgl2020, FgraEgl2010, FgraEgll020, FgraEgl2020 and 
NcraEgl2010. This study completed the detailed characterization of AfumEgl2010, 
AnidEgl2020, and FgraEgl2010. An example of the initial screening results of one 
functionally expressed target endoglucanase, FgraEgl2010, and a target endoglucanase, 
FgraEgl4020, that was not expressed at levels significantly above background is shown in 
Figure 8. 
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Figure 8: Screening for endoglucanase activity. A. Screening results for independent 
transformants obtained with functionally expressed target endoglucanase FgraEgl2010. 
FgraEgl2010 was expressed at much higher levels than the VTO control. The halos 
indicated by ovals in the lower image in Panel A were generated by a commercial 
endoglucanase II (Megazyme). Ovals in the top image of Panel A identify the 
independent transformants that were chosen for further characterization. B. Initial 
screening results obtained with FgraEgl4020 that did not express endoglucanase at levels 
that were significantly above background expression by the VTO control. 
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3.5 Protein sequence analysis of three functionally expressed endoglucanases 
The A Conserved Domain Database and Search Service (NCBI) was used to predict 
the glycoside hydrolase family and conserved domains for each target endoglucanase. 
The results showed all three endoglucanases (AfumEgl2010, AnidEgl2020, and 
FgraEgl2010) belong to glycoside hydrolase family 5 (data not shown). In addition to the 
GH family domain, one of the endoglucanases (AfumEgl2010) has a carbohydrate-
binding module (CBM) (Figure 9). The SignalP tool was used to predict whether the 
three endoglucanases had signal peptide that could direct secretion. SignalP predicted that 
all three target endoglucanases had signal peptides (Figure 9). The number of amino acids 
in the predicted signal peptides for AfumEgl2010, AnidEgl2020, and FgraEgl2010 were 
16 aa, 17 aa and 18 aa respectively. The three target endoglucanases were aligned with 
the T. reesei Eg2/Cel5A (Genebank accession #: Ml9373) and the two proteins (1GZJ|A 
and 1H1N|A) that were used to predict the 3D structure of the catalytic domains of the 
three target enzymes. The ClustalW2 alignment (Figure 9) identified the two conserved 
catalytic glutamic acid residues that were predicted to be the catalytic site amino acid. 
The predicted molecular masses of AfumEgl2010, AnidEgl2020, and FgraEgl2010 were 
41.0, 35.0 and 35.3 kDa, without signal peptide. 
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Figure 9: Protein sequence alignments using ClustalW2. Alignment of Afu 
(AfumEgl2010), An (AnidEgl2020), and Fgra (FgraEgl2010), 1GZJ/A, and 1H1N/A with 
the T. reesei Cel5A (Eg2/Cel5A) (Genebank accession #: Ml9373). 1GZJ/A 
(gi|23200107) was used as template to predict the 3D structure of the catalytic domains of 
AfumEgl2010 and AnidEgl2020. 1H1N/A (gi|23200122) was used as template to predict 
the 3D structure of the catalytic domain of the FgraEgl2010. The residues highlighted in 
grey are the predicted catalytic residues. Regions labelled by a dotted line represent 
secretory N terminal pre-sequences (signal peptide sequence); regions boxed represent 
carbohydrate-binding module (CBM); regions with a double line below them represent 






cei5A MNKSVAPLLLAASILYGGAVAQQT|VWGQCGGIGWSGPTNCAPGSACSTLNPYY[AQCIPGA 60 
1GZJIA KVFOWFGSHESGAEFGSONLPGVEGKDYIW 30 
1H1NIA AKVFOWFGSNESGAEFGSONLPGVEGKDYIW 31 
Afu MKASTIICALLPLAVAAPNAKR—ASGFVWFGSNESGAEFGETKLPGVLGTDYIW 53 
An MKVNTLLVAVAAGTAMAAPQLKK--PAGFTFFGVTEAGAEFGEKSIPGVWGTDYTF 54 
Fgra MRFTDLLLASAGATLALAAPSTEKRAAGKFLFTGSNESGGEFGETOLPGKLGKDYIW 57 
Cel5A TTITTSTRPPSGPTTTTRATSTSSSTPPTSSGVRFAGVNIAGFDFGCTTDGTCVTSKVYP 120 
1GZJ|A PDP NTIDTLISKGMNIFRVPFMMERLVPNSMTGSPDPNYLADLIATV 77 
1H1NIA PDP NTIDTLISKGMNIFRVPFMMERLVPNSMTGSPDPNYLADLIATV 78 
Afu PDA STIKTLHDAGMNIFRVAFRMERLIPNOMTGTPDATYLNDLKATV 100 
An PPT ESILTLISKGFNTFRIPFLMERLTP-EMTGSFDEGYLKNLTSVV 100 
Fgra £XJ KSIDTLASTGMNTFRVGFRMERMTPSGITGALDETYFjjGLESVV 104 
Cel5A PLKNFTGSNNYPDGIGOMOHFVNEDGMTIFRLPVGWOYLVNNHLGGNLDSTSISKYDOLV 180 
1GZJ|A NAITOKG—AYAWDPHNYGRYYNSIIS SPSDFOTFWKTVASOFASNPLVIFDTN- 130 
1H1N|A NAITOKG—AYAVVDPHN YGRY YN S11S SPSDFETFWKTVASOFASNPLVIFDTD- 131 
Afu NAITSLG—AYAVIDPHNYGRYYGN IIS STDDFAAFWKTLAAOFASNDHyIFDTN- 153 
An NAVTDAG—AffAIVDAONFGRFNGEIIS SASDFOTWWKMVAAEFADNKNVIFDTTN 154 
Fgra NHITSKHRGNFAVIDPHNYGRYNNOIIQ STADFGAWWSKVAKRFANNKNVIFDTN- 159 
Cel5A OGCLSLG—AYCIVDIHNYARWNGGIIGOGGPTNAOFTSLWSQLASKYASOSRVWFGIMN 238 
1GZJ|A N1YHDMDOTLVLNLNOAAIDGIRSAGATSOYIFVEGNSWTGAWTWTNVMDM--MK 183 
1H1N|A NiYHDMDOTLVLNLMOAAIDGIRSAGATSOYIFVEGNSWTGAWTWTNVNDN—ME 184 
Afu NiYHDMDOTLVLNLNQAAINAIRAAGATSOYIFVEGNSWSGAWTWTTVNDN—Lg 206 
An TSGADNMFHDMDOTLVLDLNOAAINGIRAAGATSOYIFVEGNSYTGAWTMTDNNDN — LJ 212 
Fgra NgYHDMENSLVAGLNOAAIDAIRKAGATSOYIFVEGNSYTGAHSWVSSGNGEALK 214 
Cel5A jlPHDVNINTWAATVOEVVTAIRNAGATSOFISLPGNDWOSAGAFISDGSAAALS 292 
1GZJIA SLTDPSD KIIYEMHOYLDSDGSGTSATCVSSTIGOERITSATOWLRANGKKGIIGIF 240 
1H1N|A SLTDPSD KIIYEMHOYLDSDGSGTSATCVSSTIGOERITSATOWLRANGKKGIIGgF 241 
Afu ALTDPOD KIVYEMHOYLDSDGSGTSATCVSSTIGOERVOAATOWLKTNGKKGIIGIF 263 
An SLTDPOD KIVYEMHOYLDTDGSGTHETCVSETIGAERVESATOWLKDNGKLGVIGltF 2 69 
Fgra NLKDPON KIIYOMHOYLDSDNSGTHADCVSSTIGYERVKEATKWLKDNKKRGIIGJBT 271 
Cel5A OVTNPDGSTTNLIFDVHKYLDSDNSGTHAECTTNNIDG-AFSPLATWI,RONNRQAILT|T 351 
1GZJ|A AGGANDVCETAITGMLDYMAONTDVWTGAIWWAAGPWWGDYIFSMEPDNGIAYQQrLPIL 300 
1H1NIA AGGADNVCETAITGMLDYMAONTDVWTGAIWWAAGPWWGDYIFSMEPDNGIAYQQILPIL 301 
Afu AGGANSVCOSAVTGMLDYLSAHSDVWMGAAVfWAAGPWWADYIFNMEPPSGTAYONYLSLL 323 
An AGGNNEICRAAVKSLLDALKENDDVWLGALWWAAGPWWEDYMFSMEPTDGIAYTGMLSTL 329 
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The 3D structure of the catalytic domains of the three target endoglucanases were 
predicted using Swiss-Model software. The structure of Thermoascus aurantiacus family 
5 endoglucanase (accession: 1GZJ/A; gi/23200107) was used as template to predict the 
3D structures of the catalytic domains of AfumEgl2010 and AnidEgl2020 (Figure 10 and 
11 respectively). Thermoascus aurantiacus family 5 endoglucanase has 77% amino acid 
sequence identity with AfumEgl2010 and 65% identity with AnidEgl2020. The atomic 
resolution structure of the major endoglucanase from Thermoascus aurantiacus 
(accession: 1H1N/A; gi/23200122) was used as the template structure to model the 3D 
structure of the catalytic domain of FgraEgl2010 (Figure 12). FgraEgl2010 and 1H1N/A 
share 60% amino acid sequence identity. All three modelled endoglucanases showed an 
eight fold (a/p) barrel structure. The predicted catalytic residues were glutamic acid 
residues 155 and 262 for AfumEgl2010, residues 161 and 268 for AnidEgl2020 and 
residues 161 and 270 for FgraEgl2010. The predicted catalytic glutamates of all three 
modelled endoglucanases were located on opposite interior walls of the (a/p) barrel. 
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Figure 10: Predicted 3D structure of the catalytic domain of AfumEgl2010. The two 
predicted catalytic residues, glutamic acid residues 155 and 262, are shown in the ball 
and stick format, and rest of the protein in ribbon format. 
Figure 11: Predicted 3D structure of the catalytic domain of AnidEgl2020. The two 
predicted catalytic residues, glutamic acid 161 and 268. are shown in the ball and stick 
format, and rest of the protein in ribbon format. 
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Figure 12: Predicted 3D structure of the catalytic domain of FgraEgI2010. The two 
predicted catalytic residues, glutamic acid 161 and 270, are shown in the ball and stick 
format, and rest of the protein m ribbon format 
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3.6 Target endoglucanase expression and desalting 
A total of three functionally expressed endoglucanases (AfumEgl2010, AnidEgl2020 
and FgraEgl2010) were chosen from the initial screening experiments for further 
biochemical characterization. For each target endoglucanase, the four individual 
transformants that showed the highest activity in the initial screening were used to 
inoculate MMJ micro plate well cultures in Petri dishes as described in section 2.7. The 
culture filtrate containing the target endoglucanase was partially purified through 
Ultrafree-0.5 centrifugal filter devices (Millipore) as described in section 2.7. The culture 
filtrate was assayed for residual sugar essentially as described in section 2.10.1 except 
that substrate was not added. The results showed the purification step successfully 
removed any remaining sugar in the culture filtrate (data not shown). The presence and 
expression level in the four individual transformants of each target secreted 
endoglucanase was estimated on SDS-PAGE gel as described in section 2.9. The results 
(Figure 13) showed that the estimated molecular mass of AfumEgl2010 was 46.0 kDa 
and AnidEgl2020 was 35.0 kDa. In Figure 14, the estimated molecular mass of 
FgraEgl2010 was 33.0 kDa. Enzyme activity assay as described in section 2.10.1 was 
also performed to check the activity of endoglucanase expressed by each transformant. 
Based on the SDS-PAGE gel and enzyme activity assay results (data not shown), 
transformants #36 and #43 (Figure 13), and #60 (Figure 14) of AnidEgl2020, 
AfumEgl2010 and FgraEgl2010, respectively were chosen for further detailed 
characterization. Three cDNA-derived endoglucanases (ApulSEQ15654, StheSEQ13822 
and GtraSEQ630) were also chosen for detail characterization. 
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#SM0431 An(#1) #35 #36 #43 Afu(#15) #43 #44 #54 VTO 
Figure 13: SDS-PAGE analysis of four independent A. niger transformants obtained 
with An (AnidEgl2020) and Afu (AfumEgl2010). 
#SM0431 Fgra(#8) #50 #55 #60 #SM0431 #SM0431 VTO 
Figure 14: SDS-PAGE analysis of four independent A niger transformants obtained 
with Fgra (FgraEgl2010). 
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3.7 Protein concentration determination 
Protein concentrations of 3 genomic and 3 cDNA derived, as well as T. reesei 
Cbhl/Cel7A (Iogen Corp.) and T. reesei Eg2/Cel5A (Iogen Corp.) were determined as 
described in section 2.9. The SDS-PAGE gel images that used to determine the protein 
concentrations are shown in Figures 15 and 16. The predicted and estimated molecular 
masses of the proteins and protein concentration of target endoglucanases are shown in 
Table 10. 
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#SM0431 Bovine serum albumin (v g) Fgra(10>:} £Ju(10x) An (10x) 17-044S-01 
Figure 15: The SDS-PAGE gel of Fgra, Afu and An. Each diluted 10 fold (lOx). Fgra 
(FgraEgl20lO), Afu (AfumEgl2010) and An (AnidEgl2020). 
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#SM0431 Apul(2x) 6tra(2x) Sthe(IOx) C8H1(50x)Eg2(lQx) Bovine serum albumin j v g) 
Figure 16: The SDS-PAGE gel of Apul, Gtra, Sthe, CBHl, and Eg2. Apul 
(ApulSEQ 15654) (2x), Gtra (GtraSEQ630) (2x), Sthe (StheSEQ 13822) (lOx), CBHl 
(Cbhl/Cel7A) (50x) (Iogen Corp.) and Eg2 (Eg2/Cel5A) (lOx) (Iogen Corp.). 
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Table 10: The predicted molecular mass (kDa), estimated molecular mass (kDa) and estimated protein 
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 Final concentration of target endoglucanases after sugar was removed. 
b
 T reesei Cbhl/Cel7A obtained from Iogen Corporation. 
c
 T. reesei Eg2/Cel5A obtained from Iogen Corporation. 
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3.8 Basic characterization of target endoglucanases 
The optimal pH of three endoglucanases (AfumEgl2010, AnidEgl2020 and 
FgraEgl2010) was determined as described in section 2.10.2. All three target 
endoglucanases showed the highest activity in citrate buffer pH 5.0 (Figure 17). To 
determine the optimal temperature, the method described in section 2.10.3 was used. 
AfumEgl2010 and AnidEgl2020 showed maximal activity at temperatures of 70°C and 
60°C respectively. FgraEgl2010 showed maximal activity at a relatively low optimal 
temperature of 40°C (Figure 18). The thermostability assay was performed as described 
in section 2.10.4. All three endoglucanases were stable during 30 minutes pre-incubation 
at 60°C (Figure 19). Compared to AnidEgl2020 and FgraEgl2010, AfumEgl2010 is the 
most stable endoglucanase. AfumEgl2010, AnidEgl2020 and FgraEgl2010 retained half 
of their activity during a 30 minute pre-incubation at 75°C, 65°C and 70°C respectively 
(Figure 19). 
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Figure 17: The pH profiles of An, Afu and Fgra at their optimal temperature. An 
(AnidEgl2020), Afu (AfumEgl2010), Fgra (FgraEgl2010) 
Temperature profile at optimal pH 
Figure 18: The temperature profiles of An, Afu and Fgra at their optimal pH. An 
(AnidEgl2020), Afu (AfumEgl2010), Fgra (FgraEgl2010) 
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Figure 19: The thermostability profiles of An, Afu and Fgra after a 30 minute pre-
incubation at temperature from 25°C to 80°C. An (AnidEgl2020), Afu (AfumEgl2010), 
Fgra(FgraEgl2010) 
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3.9 Enzyme kinetics of target endoglucanases 
The kinetic parameters of the six endoglucanases and the T. reesei Eg2/Cel5 A (Iogen 
Corp.) were determined as described in section 2.11. The results are shown in Table 11. 
The Km values range from 2.0 to 29 mg PASC/ml. The Vmax values range from 5.7 to 
41 pmole of reducing sugar ends per mg of enzyme per minute. The kcat values range 
from 4/sec to 29/sec. The kcat/Km ratio is also shown in Table 11. AfumEgl2010 has the 
highest kcat/Km ratio of 3.0 which is 2 times higher than the kcat/Km ratio of the T. 
reesei Eg2/Cel5A (Iogen Corp.). AnidEgl2020 has a significantly lower kcat/Km ratio of 
0.1 compared to that of T. reesei Eg2/Cel5A (Iogen Corp.). 
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Table 11: Enzyme kinetic parameters of 6 endoglucanases and the Eg2/Cel5A at 



































































 T reesei Eg2/Cel5A obtained from Iogen Corporation. 
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3.10 Synergy assays of target endoglucanases 
Synergy assays were performed using either Avicel or PASC as described in section 
2.12. The degree of synergism is determined by the ratio between the experimental 
enzyme activity of the combined enzyme mixture and the added enzyme activities of the 
individual enzymes (Zhang and Lynd, 2004). The synergy assay results of the target 
endoglucanases combined with the T. reesei Cbhl/Cel7A are shown in Figure 20. Based 
on these results, all the target enzymes showed a higher degree of synergism on Avicel 
than on PASC (Table 12). On Avicel, T. reesei Eg2/Cel5A (Iogen Corp.) showed the 
highest degree of synergism of 3.3 when combined with the T. reesei Cbhl/Cel7A (Iogen 
Corp.). AfumEgl2010 combined with the T. reesei Cbhl/Cel7A (Iogen Corp.) showed a 
maximal degree of synergism of 2.9. AnidEgl2020 showed the lowest degree of 
synergism of 1.3. On PASC, the highest degree of synergism was observed when 
AfumEgl2010 was combined with the T. reesei Cbhl/Cel7A (Iogen Corp.). The lowest 
degree of synergism on PASC was observed when AnidEgl2020 was combined with the 
T. reesei Cbhl/Cel7A (Iogen Corp.). 
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Figure 20: The degree of synergism when the target endoglucanases were combined 
with the T. reesei Cbhl/Cel7A (Iogen Corp.). The top x axis is the amount of 
endoglucanase that was added into each enzyme assay. The bottom x axis is the amount 
of exoglucanase that was added into each enzyme assay. The data points in blue indicate 
the enzyme activity of the T. reesei Cbhl/Cel7A (Iogen Corp.) alone at different 
concentrations. The data points in plum indicate the enzyme activity of endoglucanase 
alone at different concentrations. The data points in lime indicate the added activity of 
individual enzyme activity of the T. reesei Cbhl/Cel7A (Iogen Corp.) and an 
endoglucanase at the concentration indicated on the lower and upper x-axis. The data 
points in blue-gray indicate the experimental enzyme activity of combining the T. reesei 
Cbhl/Cel7A (Iogen Corp.) and the endoglucanase at the concentration indicated on the 
lower and upper x-axis. The arrows on the figure indicate the combination of the T. reesei 
Cbhl/Cel7A (Iogen Corp.) and the endoglucanase that gives the highest degree of 
synergism. In the figure, 0.1 OD equals to 0.0056 pmole/min/ml, which is pmole of 
reducing sugar ends produced per minute per ml of enzyme. In the figure, cbhl represents 
the T. reesei Cbhl/Cel7A obtained from Iogen Corporation; eg2 represents the T. reesei 
Eg2/Cel5A obtained from Iogen Corporation. 
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Figure 20A: Synergy of cbhl (Cbhl7Cel7A) and eg2 (Eg2/Cel5A). (0.1 OD equals to 
0.0056 pmole/min/ml.) 














Figure 20B: Synergy of cbhl (Cbhl/Cel7A) and an (AnidEgl2020). (0.1 OD equals to 
0.0056 pmole/min/ml) 
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Figure 20C: Synergy of cbhl (Cbhl/CeI7A) and afu (AfumEgl2010). (0.1 OD equals 
to 0.0056 pmole/min/ml) 
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Figure 20D: Synergy of cbhl (Cbhl/Cel7A) and fgra (FgraEgl2010). (0.1 OD equals 
to 0.0056 pmole/min/ml) 







Figure 20E: Synergy of cbhl (Cbhl/Cel7A) and apul (ApulSEQ15654). (0.1 OD 
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Figure 20F: Synergy of cbhl (Cbhl/Cel7A) and sthe (StheSEQ13822). (0.1 OD 
equals to 0.0056 pmole/min/ml) 
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Figure 20G: Synergy of cbhl (Cbhl/Cel7A) and gtra (GtraSEQ630). (0.1 OD equals 
to 0.0056 umole/min/ml) 
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Deg ;ree of synergism3 
Avicel 
10.2 pmole Cbhl1 and 1.36 pmole Eg2 
10.2 pmole Cbhl and 1.36 pmole An 
10.2-pmole Cbhl and 1.36 pmole Afu 
10.2 pmole Cbhl and 1.36 pmole Fgra 
20.4 pmole Cbhl and 0.91 pmole Apul 
10.2 pmole Cbhl and 1.36 pmole Sthe 









3.4 pmole Cbhl and 0.68 pmole Eg2 
10.2 pmole Cbhl and 0.23 pmole An 
3.4 pmole Cbhl and 0.68 pmole Afu 
10.2 pmole Cbhl and 0.23 pmole Fgra 
10.2 pmole Cbhl and 0.23 pmole Apul 
10.2 pmole Cbhl and 0.23 pmole Sthe 








"Degree of synergism presented for each enzyme combination is equal to highest ratio of the observed combined activity divided 
by the predicted activity obtained by adding the activities of the individual enzymes. 
Eg2 represents T. reesei Eg2/Cel5A obtained from Iogen Corporation. 
c
 An represents AnidEgl2020. 
d
 Afu represents AfumEgl2010. 
e
 Fgra represents FgraEgl2010. 
f
 Apul represents ApulSEQ15654. 
g
 Sthe represents StheSEQ 13 822. 
h
 Gtra represents GtraSEQ630. 
1
 Cbhl represents T. reesei Cbhl/Cel7A obtained from Iogen Corporation. 
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4. Discussion 
4.1 Isolation of putative cellulase genes 
I cloned a set of cDNA-derived and a set of genomic DNA-derived genes that code 
for proteins that are predicted to be secreted enzymes or accessory proteins that are active 
on cellulose or hemicellulose. The genomic DNA-derived set included 207 genes from 13 
different fungal species. We chose these 13 different fungal species because their 
complete genome sequences were available, they are known to degrade plant biomass 
and their cellulase systems are not well characterized. 
4.2 Identification of functionally expressed endoglucanases 
In this study, I performed an initial screening of 51 of the endoglucanase coding 
genes from the genomic DNA-derived set. From this set, I identified six functionally 
expressed endoglucanases. From previous experiments the success rate in identifying 
functionally expressed fungal enzymes is around 30% (Personal communication, Dr. 
Storms). Compared to that, my success rate (12%) is relatively low. In order to explain 
that, we sent these 51 cloned endoglucanase genes for sequencing. The sequencing results 
showed that 25 of the completely sequenced target genes were 100% identical with the 
fungal genome database sequence. Eight partially sequenced genes were found to be 
100% identical with the fungal genome database sequence. One of the sequenced genes 
has one silent mutation. The rest of the 17 endoglucanase genes were found to have at 
least one missense mutation. The mutations may be the result of PCR amplification using 
a Taq and Pfu polymerase mix. These mutations in the target protein can be one 
90 
explanation for the low success rate of identifying functionally expressed endoglucanases. 
Another reason could be due to the use of genomic DNA as the template. When genomic 
DNA is used as template, the introns of target genes are also cloned and thus have to be 
removed before translation. Since the target proteins are encoded by heterologous genes, 
there is the possibility that the introns are not correctly spliced by A. niger. However, 
previous studies in our laboratory found that the expression of 3 heterologous xylanases 
cloned from Phanerochaete chrysosporium was similar whether the cloned genes were 
derived using cDNA or genomic DNA (Decelle, 2006). Other possible explanations for 
the low success rate are; background activity may have masked the expression of genes 
that were expressed at low levels and, the wrong substrates were used to test for activity. 
4.3 Bioinformatic analysis of functionally expressed endoglucanases 
From the six functionally expressed endoglucanases, I chose three for detailed 
analysis. The three target endoglucanases that were chosen all belong to glycoside 
hydrolase family 5 (GH5) as determined by blastp (NCBI). Previous studies of Cel5A 
from T. reesei, also a member of the GH5 family, showed that it has a CBM located at 
the N terminus (Saloheimo et al., 1988). However, my Blast analysis showed that 
AnidEgl2020 and FgraEgl2010 do not have a CBM. The third endoglucanase, 
AfumEgl2010, has a CBM at its C terminus. 
Two 3D structures of Cel5A proteins (accession: 1GZJ/A; gi/23200107, accession: 
1H1N/A; gi/23200122) were used to model 3D structures of the catalytic domains of the 
three GH5 endoglucanases. All three modelled endoglucanases showed an eight fold (a/|3) 
barrel structure, which is similar to the structure found in other GH5 family 
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endoglucanases (Davies et al., 1998). From the protein sequence alignment results, the 
predicted catalytic residues of my three target endoglucanases were determined using the 
catalytic residues as previously determined (Lo Leggio and Larsen, 2002; Van Petegem 
et al., 2002 ). The predicted catalytic residues were glutamic acid residues 155 and 262 
for AfumEgl2010, residues 161 and 268 for AnidEgl2020 and residues 161 and 270 for 
FgraEgl2010. 
4.4 Characterization of the functionally expressed endoglucanases 
Basic biochemical characterization of the selected endoglucanases was performed. 
The pH profile, temperature profile and thermostability were determined for each of the 
three GH5 endoglucanases. The optimal pH of the three GH5 endoglucanases was pH 5.0. 
The optimal temperature of the three GH5 endoglucanases ranged from 40°C to 70°C. All 
three GH5 endoglucanases retained activity after a 30 minute pre-incubation at 60°C. 
The optimal temperature of T. reesei Cel5A purified from T. reesei culture filtrates is 
70°C (Karlsson et al., 2002). Subsequent studies reported that the optimal pH of T reesei 
Cel5A expressed in T. reesei ranged from pH 4.6 to 5.0, and that Cel5A lost 50% of its 
activity when incubated at 70°C for 30 minutes (Qin et al., 2008). The superior 
thermostability of the AfumEgl2010 cellulase that I identified and characterized in this 
study may make it an attractive replacement for T reesei Cel5A in future commercial 
preparations of the T. reesei cellulase system used for industrial scale cellulose hydrolysis. 
I determined the kinetic parameters of 7 endoglucanases. These endoglucanases are 
the three I identified, the T. reesei Eg2/Cel5A obtained from Iogen Corporation, and three 
endoglucanases that were identified by undergraduate student Christopher St-Francois. 
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Three endoglucanases (GtraSEQ630, FgraEgl2010, AnidEgl2020) all without a CBM 
showed higher Km values than the other four endoglucanases (ApulSEQ 15654, 
StheSEQ 13 822, AfumEgl2010, Eg2/Cel5A) containing a CBM. The Km represents how 
efficiently the enzyme binds to the substrate. The lower Km associated with the four 
enzymes harbour CBMs is consistent with the CBM contributing to higher substrate 
binding efficiency (Champe et al., 2007). When comparing the Km values of the six 
endoglucanases and the T. reesei Eg2/Cel5A (which is used in industry to convert the 
cellulosic biomass to fermentable sugars), AfumEgl2010 has the lowest Km of 2.0 mg/ml, 
T. reesei Eg2/Cel5A has a Km of 2.6 mg/ml and StheSEQ13822 has a Km of 3.3 mg/ml. 
When comparing the kcat/Km values, which indicate how efficiently the enzyme 
degrades its substrate (Eun, 1996), three of the endoglucanases (ApulSEQ 15654, 
StheSEQ 13 822, AfumEgl2010) show higher kcat/Km values when compared with the T. 
reesei Eg2/Cel5A. For industrial applications, using less enzyme through increased 
enzyme efficiency, will lead to a reduction in the cost of cellulose hydrolysis for 
bioethanol production. ApulSEQ15654, StheSEQ13822 or AfumEgl2010 endoglucanases 
may be good candidates to replace the T. reesei Eg2/Cel5A in a commercial cellulase 
system because these three endoglucanases have higher kcat/Km values. However, 
further work needs to be done in order to confirm the commercial potential of these 
endoglucanases to supplement or replace Eg2/Cel5A in the T reesei cellulases system 
used industrially. To begin, these three endoglucanases could be added to a commercial 
cellulase system lacking Eg2/Cel5A to see how they perform relative to the T reesei 
Eg2/Cel5A. 
93 
4.5 Synergy analysis 
In assessing synergy between each of the seven endoglucanases and the T. reesei 
Cbhl/Cel7A (Iogen Corp.), two substrates were used: Avicel, a microcrystalline cellulose 
and PASC, an amorphous cellulose. According to my results, the degree of synergism 
using Avicel is higher than the degree of synergism using PASC for all the 
endoglucanases tested in combination with the T. reesei Cbhl/Cel7A (Iogen Corp.). My 
results agree with results reported previously (Nidetzky et al., 1993). These authors found 
that the degree of synergism was higher on microcrystalline cellulose than amorphous 
cellulose. This is probably due to microcrystalline cellulose having relatively few 
accessible sites for endoglucanases and therefore exoglucanases can generate new sites 
for endoglucanase access (Teeri, 1997). On the other hand, endoglucanases and 
exoglucanases showed less cooperativity on amorphous cellulose (PASC) because 
endoglucanases have access to more sites on amorphous cellulose. Comparing the degree 
of synergism of different target endoglucanases on Avicel or PASC, generally, the results 
show that the endoglucanases with a CBM have a higher degree of synergism compared 
with the endoglucanases without a CBM. For example, AfumEgl2010 which has a CBM 
shows a high degree of synergism with the T. reesei Cbhl/Cel7A (Iogen Corp.) when 
using both PASC and Avicel. On the other hand, AnidEgl2020 which does not have a 
CBM shows the lowest degree of synergism under both conditions. The function of the 
CBM may explain the differences observed because the presence of a CBM can increase 
enzyme efficiency by helping the enzyme stay close to the substrate (Din et al., 1994). 
My results support this possibility since T. reesei Eg2/Cel5A and AfumEgl2010 had the 
highest degree of synergism, 3.3 and 2.9 respectively, and AnidEgI2020 had the lowest 
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degree of synergism, 1.3, when using Avicel. Since there are several factors, such as the 
amount of enzyme loaded, the reaction time, presence or absence of inhibitors, which can 
affect the degree of synergism, we can vary these factors to assess their effect on synergy 
(Zhang and Lynd, 2004). For example, we can add P-glucosidases into the synergy assays 
to see whether p-glucosidases can increase the degree of synergism. Also, we can use a 
greater number of concentrations when we vary the amount of each enzyme that was used 
in the synergy assays. 
4.6 Future perspectives 
Analysis of the signal peptides of functionally expressed endoglucanases in A. niger 
and other highly expressed secreted proteins could be informative in order to find the 
common signal peptide feature that support efficient secretion. Once the conserved 
features are identified, we can perhaps construct an optimized signal peptide. The 
optimized signal peptide could then be used to replace the native signal peptides of target 
proteins that are poorly secreted by A. niger. 
Currently, the expressed endoglucanases in A. niger are not truly purified. There may 
be other secreted proteins present that may affect the results of initial screening and 
biochemical characterization. To solve this problem, a high throughput method for 
heterologous protein purification could be developed. Since the CBM can bind with the 
insoluble cellulose, it might be possible to fuse target proteins to a CBM and use it as a 
tag to purify heterologous proteins expressed in A, niger. Another approach that could be 
used to obtain pure proteins is to eliminate background enzyme activity from the culture 
filtrates. This could be done using mass spectrometry to identify the secreted proteins 
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